Back to search
PL

PL · PL · PL-100477946

Skyrizi

ATC L04AC18

Last synced from URPL (Poland) on

Identification

ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeL04AC18
Dispensing
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026

Packs · 1

  • gtin
    08054083025186

Annotations

No annotations yet.

Raw payload (JSON)
{
  "form": "Roztwór do wstrzykiwań we wkładzie",
  "source": "urpl",
  "strength": "360 mg",
  "packaging": "08054083025186 ¦ Rpz ¦ EU/1/19/1361/005 ¦ 148289\n1 wkład 2,4 ml + 1 osobisty aplikator do wstrzyknięcia podskórnego",
  "substance": "Risankizumabum 150 mg/ml",
  "common_name": "Risankizumabum",
  "pl_product_id": "100477946",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

Related drugs

Other records sharing ATC code L04AC18.

Access this data programmatically

Query Skyrizi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.